In 2022, the Chinese pharmaceutical firm Innovent Biologics Inc. received revenue of 4.56 billion yuan from customer contracts, a 6.8 percent increase from the previous year. The core products of Innovent Biologics include anti-tumor medicines and drugs treating metabolic disorders and autoimmune diseases.
Revenue from customer contracts of Innovent Biologics Inc. from 2019 to 2022
(in billion yuan)
Adjust the presentation of the statistic and data points.
Share the statistic on social media channels or embed the statistic in your
website using "Embed Code", where available.
Cite this statistic and select one of the following formats: APA, Chicago, Harvard, MLA & Bluebook.
Print the statistic including description and metadata.
Chart type
Revenue from customer contracts of Innovent Biologics Inc. from 2019 to 2022
Share this statistic
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
Innovent Biologics. (March 28, 2023). Revenue from customer contracts of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan) [Graph]. In Statista. Retrieved January 05, 2025, from https://www.statista.com/statistics/1404673/chinese-pharmaceuticals-innovent-biologics-customer-contract-revenue/
Innovent Biologics. "Revenue from customer contracts of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan)." Chart. March 28, 2023. Statista. Accessed January 05, 2025. https://www.statista.com/statistics/1404673/chinese-pharmaceuticals-innovent-biologics-customer-contract-revenue/
Innovent Biologics. (2023). Revenue from customer contracts of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan). Statista. Statista Inc.. Accessed: January 05, 2025. https://www.statista.com/statistics/1404673/chinese-pharmaceuticals-innovent-biologics-customer-contract-revenue/
Innovent Biologics. "Revenue from Customer Contracts of Innovent Biologics Inc. from 2019 to 2022 (in Billion Yuan)." Statista, Statista Inc., 28 Mar 2023, https://www.statista.com/statistics/1404673/chinese-pharmaceuticals-innovent-biologics-customer-contract-revenue/
Innovent Biologics, Revenue from customer contracts of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan) Statista, https://www.statista.com/statistics/1404673/chinese-pharmaceuticals-innovent-biologics-customer-contract-revenue/ (last visited January 05, 2025)
Revenue from customer contracts of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan) [Graph], Innovent Biologics, March 28, 2023. [Online]. Available: https://www.statista.com/statistics/1404673/chinese-pharmaceuticals-innovent-biologics-customer-contract-revenue/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.